Leerink Partnrs Issues Optimistic Estimate for CRSP Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Stock analysts at Leerink Partnrs boosted their Q1 2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics in a note issued to investors on Monday, February 24th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will earn ($1.25) per share for the quarter, […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Stock analysts at Leerink Partnrs boosted their Q1 2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics in a note issued to investors on Monday, February 24th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will earn ($1.25) per share for the quarter, […]
